Impact of hypertension and hypertension-related vascular lesions in IgA nephropathy

Hypertension Research

Volumn 29, Issue 1, 2006, Pages 15-22

  Ikee, Ryota ^a,b   Kobayashi, Shuzo ^b   Saigusa, Takamitsu ^a   Namikoshi, Tamehachi ^a   Yamada, Muneharu ^a   Hemmi, Noriaki ^a   Imakiire, Toshihiko ^a   Kikuchi, Yuichi ^a   Suzuki, Shigenobu ^a   Miura, Soichiro ^a  

^a NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^b SHONAN KAMAKURA GENERAL HOSPITAL   (Japan)

Author keywords

Arteriosclerosis; Glomerular sclerosis; IgA nephropathy; Proteinuria; Tubulointerstitium

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; ANTITHROMBOCYTIC AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ICOSAPENTAENOIC ACID; IMMUNOGLOBULIN A; PREDNISOLONE;

ADULT; AGE; AGED; ARTICLE; CELL PROLIFERATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; GLOMERULOSCLEROSIS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOGLOBULIN A NEPHROPATHY; INTERSTITIAL NEPHRITIS; KIDNEY BIOPSY; KIDNEY PARENCHYMA; MALE; MESANGIUM CELL; MULTIPLE REGRESSION; NEPHROLOGIST; NEPHROSCLEROSIS; PROGNOSIS; PROTEINURIA; QUANTITATIVE ANALYSIS; RENOVASCULAR DISEASE; RISK FACTOR; SCHOOL CHILD;

ADOLESCENT; ADULT; AGE FACTORS; AGED; ATHEROSCLEROSIS; CHILD; FEMALE; GLOMERULAR MESANGIUM; GLOMERULONEPHRITIS, IGA; HUMANS; HYPERTENSION, RENAL; KIDNEY; KIDNEY GLOMERULUS; MALE; MIDDLE AGED; PROTEINURIA; REGRESSION ANALYSIS; RISK FACTORS; VASCULAR DISEASES;

EID: 33645211225     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.29.15     Document Type: Article

References (28)

1. Feiner HD, Cabili S, Baldwin DS, Schacht RG, Gallo GR: Intrarenal vascular sclerosis in IgA nephropathy. Clin Nephrol 1982; 18: 183-192.
2. Alamartine E, Sabatier JC, Berthoux FC: Comparison of pathological lesions on repeated renal biopsies in 73 patients with primary IgA glomerulonephritis: value of quantitative scoring and approach to final prognosis. Clin Nephrol 1990; 34: 45-51.
3. Katafuchi R, Vamvakas E, Neelakantappa K, Baldwin DS, Gallo GR: Microvascular disease and the progression of IgA nephropathy. Am J Kidney Dis 1990; 15: 72-79.
4. Osawa Y, Narita I, Imai N, et al: Determination of optimal blood pressure for patients with IgA nephropathy based on renal histology. Hypertens Res 2001; 24: 89-92.
5. D'Amico G: Natural history of idiopathic IgA nephropathy: role of clinical and histological prognostic factors. Am J Kidney Dis 2000; 36: 227-237.
6. Szeto CC, Lai FM, To KF, et al: The natural history of immunoglobulin A nephropathy among patients with hematuria and minimal proteinuria. Am J Med 2001; 110: 434-437.
7. Nieuwhof C, Doorenbos C, Grave W, et al: A prospective study of the natural history of idiopathic non-proteinuric hematuria. Kidney Int 1996; 49: 222-225.
8. McGregor DO, Lynn KL, Bailey RR, Robson RA, Gardner J: Clinical audit of the use of renal biopsy in the management of isolated microscopic hematuria. Clin Nephrol 1998; 49: 345-348.
9. Hall CL, Bradley R, Kerr A, Attoti R, Peat D: Clinical value of renal biopsy in patients with asymptomatic microscopic hematuria with and without low-grade proteinuria. Clin Nephrol 2004; 62: 267-272.
10. Kobayashi S, Nagase M, Kimura M, Ohyama K, Ikeya M, Honda N: Renal involvement in mixed connective tissue disease: report of 5 cases. Am J Nephrol 1985; 5: 282-289.
11. Font J, Torras A, Cervera R, Darnell A, Revert L, Ingelmo M: Silent renal disease in systemic lupus erythematosus. Clin Nephrol 1987; 27: 283-288.
12. Ikee R, Hemmi N, Saigusa T, et al: Pathological analysis of renal diseases with mild proteinuria. Nippon Jinzo Gakkai Shi 2002; 44: 786-791 (in Japanese).
13. Eiro M, Katoh T, Kuriki M, Asano K, Watanabe K, Watanabe T: The product of duration and amount of proteinuria (proteinuria index) is a possible marker for glomerular and tubulointerstitial damage in IgA nephropathy. Nephron 2002; 90: 432-441.
14. Ibels LS, Gyory AZ: IgA nephropathy: analysis of the natural history, important factors in the progression of renal disease, and a review of the literature. Medicine (Baltimore) 1994; 73: 79-102.
15. Koyama A, Igarashi M, Kobayashi M: Natural history and risk factors for immunoglobulin A nephropathy in Japan. Am J Kidney Dis 1997; 29: 526-532.
16. Wada T, Hamakawa S, Hori Y, et al: Immunohistochemical localization of latent transforming growth factor-β binding protein in IgA nephropathy. Kidney Int 1997; 52 (Suppl 63): S182-S184.
17. Nieuwhof C, Kruytzer M, Frederiks P, van Breda Vriesman PJ: Chronicity index and mesangial IgG deposition are risk factors for hypertension and renal failure in early IgA nephropathy. Am J Kidney Dis 1998; 31: 962-970.
18. Katafuchi R, Kiyoshi Y, Oh Y, et al: Glomerular score as a prognosticator in IgA nephropathy: its usefulness and limitation. Clin Nephrol 1998; 49: 1-8.
19. D'Amico G, Imbasciati E, Barbiano Di Belgioioso G, et al: Idiopathic IgA mesangial nephropathy: clinical and histological study of 374 patients. Medicine (Baltimore) 1985; 64: 49-60.
20. Rauta V, Finne P, Fagerudd J, Rosenlof K, Tornroth T, Gronhagen-Riska C: Factors associated with progression of IgA nephropathy are related to renal function: a model for estimating risk of progression in mild disease. Clin Nephrol 2002; 58: 85-94.
21. Usui J, Yamagata K, Kai H, et al: Heterogeneity of prognosis in adult IgA nephropathy, especially with mild proteinuria or mild histological features. Intern Med 2001; 40: 697-702.
22. Konishi Y, Morikawa T, Yasu T, et al: Blunted response of the renin-angiotensin system and nitric oxide synthesis related to sodium sensitivity in immunoglobulin A nephropathy. Hypertens Res 2004; 27: 7-13.
23. Iino Y, Hayashi M, Kawamura T, et al: Renoprotective effect of losartan in comparison to amlodipine in patients with chronic kidney disease and hypertension: a report of the Japanese Losartan Therapy Intended for the Global Renal Protection in Hypertensive Patients (JLIGHT) Study. Hypertens Res 2004; 27: 21-30.
24. 1-adrenergic antagonist in spontaneously hypertensive rats with renal ablation. Hypertens Res 2004; 27: 509-515.
25. Lindeman RD: Renal physiology and pathophysiology of aging. Contrib Nephrol 1993; 105: 1-12.
26. Kaplan C, Pasternack B, Shah H, Gallo G: Age-related incidence of sclerotic glomeruli in human kidneys. Am J Pathol 1975; 80: 227-234.
27. Clarkson AR, Seymour AE, Thompson AJ, Haynes WD, Chan YL, Jackson B: IgA nephropathy: a syndrome of uniform morphology, diverse clinical features and uncertain prognosis. Clin Nephrol 1977; 8: 459-471.
28. Yaguchi Y, Tomino Y, Funabiki K, et al: Comparative studies of clinicopathologic changes in patients with adult- and juvenile-onset of IgA nephropathy. J Nephrol 1994; 7: 182-185.